A detailed history of Pale Fire Capital Se transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Pale Fire Capital Se holds 734,904 shares of CRBU stock, worth $1.44 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
734,904
Previous 39,107 1779.21%
Holding current value
$1.44 Million
Previous $64.1 Million 2145.91%
% of portfolio
0.23%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.56 - $2.73 $1.09 Million - $1.9 Million
695,797 Added 1779.21%
734,904 $1.44 Billion
Q2 2024

Aug 13, 2024

BUY
$1.62 - $5.05 $28,199 - $87,905
17,407 Added 80.22%
39,107 $64.1 Million
Q1 2024

May 14, 2024

SELL
$4.82 - $8.26 $31,330 - $53,690
-6,500 Reduced 23.05%
21,700 $112 Million
Q4 2023

Feb 13, 2024

BUY
$3.58 - $6.25 $100,956 - $176,250
28,200 New
28,200 $162 Million

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $119M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Pale Fire Capital Se Portfolio

Follow Pale Fire Capital Se and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pale Fire Capital Se, based on Form 13F filings with the SEC.

News

Stay updated on Pale Fire Capital Se with notifications on news.